4
Changes in Ownership
Ovid Therapeutics Inc. Filed Acc 0001415889-24-029472
Options or other derivatives
- Director acquired 90,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Duncan Barbara Gayle Director | 2024-12-12 | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | D | ||
Loading xslF345X05/form4-12162024_041213.xml…